Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Lippman

Showing results (301-310 of 340) with videos related to

Pageof 34
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancerBenjamin J Moeller, Vishal Rana, Blake A Cannon, et al.
International Journal of Radiation Oncology, Biology, Physics|February 23, 2010
Prospective imaging assessment of mortality risk after head-and-neck radiotherapyBenjamin J Moeller, Vishal Rana, Blake A Cannon, et al.
Small (Weinheim an Der Bergstrasse, Germany)|April 8, 2026
Liquid Biopsy Differentiation of Pancreatic Cancer From Non-Cancerous Pancreatic Disease Using Dielectrophoresis-Recovered Nanoparticles Carrying Cell-Free DNA and Protein BiomarkersAnna Malakian, Augusta Modestino, Jesus Bueno, et al.
Cancer Causes & Control : CCC|June 14, 2011
Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control studySong Yao, Cathee Till, Alan R Kristal, et al.
Urology|March 4, 2015
Effect of finasteride on serum androstenedione and risk of prostate cancer within the prostate cancer prevention trial: differential effect on high- and low-grade diseaseAshraful Hoque, Song Yao, Cathee Till, et al.
Nature Communications|October 3, 2020
Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategyShumei Kato, Ki Hwan Kim, Hyo Jeong Lim, et al.
Nature Communications|July 10, 2018
Assembly and activation of the Hippo signalome by FAT1 tumor suppressorDaniel Martin, Maria S Degese, Lynn Vitale-Cross, et al.
Cancer|January 4, 2023
Spatial PD-L1, immune-cell microenvironment, and genomic copy-number alteration patterns and drivers of invasive-disease transition in prospective oral precancer cohortWilliam N William, Jianjun Zhang, Xin Zhao, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 17, 2015
Phase Ib Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Patients with Barrett's EsophagusAndrew K Joe, Felice Schnoll-Sussman, Robert S Bresalier, et al.
Molecular Cancer Therapeutics|June 10, 2010
Serum signature of hypoxia-regulated factors is associated with progression after induction therapy in head and neck squamous cell cancerLauren Averett Byers, F Christopher Holsinger, Merrill S Kies, et al.
Pageof 34

Showing results (301-310 of 340) with videos related to

Sort By:
Pageof 34
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancerBenjamin J Moeller, Vishal Rana, Blake A Cannon, et al.
International Journal of Radiation Oncology, Biology, Physics|February 23, 2010
Prospective imaging assessment of mortality risk after head-and-neck radiotherapyBenjamin J Moeller, Vishal Rana, Blake A Cannon, et al.
Small (Weinheim an Der Bergstrasse, Germany)|April 8, 2026
Liquid Biopsy Differentiation of Pancreatic Cancer From Non-Cancerous Pancreatic Disease Using Dielectrophoresis-Recovered Nanoparticles Carrying Cell-Free DNA and Protein BiomarkersAnna Malakian, Augusta Modestino, Jesus Bueno, et al.
Cancer Causes & Control : CCC|June 14, 2011
Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control studySong Yao, Cathee Till, Alan R Kristal, et al.
Urology|March 4, 2015
Effect of finasteride on serum androstenedione and risk of prostate cancer within the prostate cancer prevention trial: differential effect on high- and low-grade diseaseAshraful Hoque, Song Yao, Cathee Till, et al.
Nature Communications|October 3, 2020
Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategyShumei Kato, Ki Hwan Kim, Hyo Jeong Lim, et al.
Nature Communications|July 10, 2018
Assembly and activation of the Hippo signalome by FAT1 tumor suppressorDaniel Martin, Maria S Degese, Lynn Vitale-Cross, et al.
Cancer|January 4, 2023
Spatial PD-L1, immune-cell microenvironment, and genomic copy-number alteration patterns and drivers of invasive-disease transition in prospective oral precancer cohortWilliam N William, Jianjun Zhang, Xin Zhao, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 17, 2015
Phase Ib Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Patients with Barrett's EsophagusAndrew K Joe, Felice Schnoll-Sussman, Robert S Bresalier, et al.
Molecular Cancer Therapeutics|June 10, 2010
Serum signature of hypoxia-regulated factors is associated with progression after induction therapy in head and neck squamous cell cancerLauren Averett Byers, F Christopher Holsinger, Merrill S Kies, et al.
Pageof 34